Lilly Kia K, Koshnick Rebecca L, Grill Joseph P, Khalil Zena M, Nelson David B, Warshaw Erin M
University of Minnesota, Minneapolis, Minnesota, USA.
J Am Acad Dermatol. 2006 Oct;55(4):620-6. doi: 10.1016/j.jaad.2006.03.033. Epub 2006 Jun 13.
Our purpose was to estimate and compare the cost-effectiveness of the most commonly used diagnostic tests for onychomycosis: potassium hydroxide preparation (KOH), interpreted both by a dermatologist (KOH-CLINIC) and a laboratory technician (KOH-LAB); KOH with dimethyl sulfoxide (KOH-DMSO) and with chlorazol black E (KOH-CBE), interpreted by a dermatologist; culture using dermatophyte test medium, culture with Mycobiotic and Inhibitory Mold Agar (Cx); and histopathologic analysis using periodic acid-Schiff stain (PAS).
This was a repeated-measure, blinded, cross-sectional study conducted at the Minneapolis Veterans Affairs Medical Center. Inclusion criteria included: at least one toenail with 25% or more clinical disease, which was defined as subungual debris with onycholysis and/or onychauxis. Exclusion criteria included other nail dystrophies, use of oral antifungal medication for 2 months or longer within the past year, or topical ciclopirox lacquer within 6 weeks of enrollment. The main outcome measure was the cost-effectiveness (Medicare and non-Medicare costs) of 7 diagnostic tests. Sensitivity (at least 3 positive tests) was the unit of effectiveness.
Two hundred four participants were enrolled; their average age was 69.5 years and 95.5% were male. PAS was the most sensitive test (98.8%); it was statistically significantly more sensitive than all other diagnostic tests except KOH-CBE (94.3%). Dermatophye test medium was the least sensitive test (57.3%). KOH-CBE was statistically significantly more cost effective than any other test, with the exception of KOH-CLINIC and KOH-LAB. PAS was the least cost effective.
Test specificities were not evaluated.
KOH-CBE should be the test of choice for practitioners confident in interpreting KOH preparations because of its combination of high sensitivity and cost-effectiveness.
我们的目的是评估和比较最常用的甲真菌病诊断测试的成本效益:氢氧化钾制剂(KOH),由皮肤科医生(KOH-CLINIC)和实验室技术人员(KOH-LAB)解读;含二甲基亚砜的KOH(KOH-DMSO)和含氯唑黑E的KOH(KOH-CBE),由皮肤科医生解读;使用皮肤癣菌测试培养基培养、使用霉菌选择性培养基和抑制性霉菌琼脂培养(Cx);以及使用过碘酸希夫染色(PAS)进行组织病理学分析。
这是一项在明尼阿波利斯退伍军人事务医疗中心进行的重复测量、盲法横断面研究。纳入标准包括:至少一个趾甲有25%或更多的临床病变,定义为伴有甲剥离和/或甲肥厚的甲下碎屑。排除标准包括其他指甲营养不良、在过去一年内使用口服抗真菌药物2个月或更长时间,或在入组前6周内使用外用环吡酮漆。主要结局指标是7种诊断测试的成本效益(医疗保险和非医疗保险成本)。敏感性(至少3次阳性测试)是有效性的单位。
招募了204名参与者;他们的平均年龄为69.5岁,95.5%为男性。PAS是最敏感的测试(98.8%);除KOH-CBE(94.3%)外,它在统计学上比所有其他诊断测试都更敏感。皮肤癣菌测试培养基是最不敏感的测试(57.3%)。KOH-CBE在统计学上比任何其他测试都更具成本效益,但KOH-CLINIC和KOH-LAB除外。PAS是成本效益最低的。
未评估测试特异性。
由于KOH-CBE具有高敏感性和成本效益的特点,对于有信心解读KOH制剂的从业者来说,它应该是首选测试。